Comparison of outcomes in sot recipients during two eras of covid-19 therapeutics
Tung‐Chuan Chiang, Robin K. Avery(Johns Hopkins University), Ahmet Gürakar(Johns Hopkins University), Darin Ostrander(Johns Hopkins University), Allan B. Massie(Johns Hopkins University), Pankaj R. Shah, C. Durand, Shmuel Shoham(Office of Infectious Diseases), Neha Desai, William A. Werbel(Johns Hopkins University), Danny Segev, M. Y. Kim, Nitipong Permpalung(Johns Hopkins University), Jacqueline Garonzik‐Wang(University of Wisconsin–Madison), Afrah S. Sait, Kieren A. Marr(Freedom to Live), M. Veronica Dioverti, Tarun Jain, W. Cochran(Geisinger Medical Center), Seema Mehta Steinke(Johns Hopkins University), D. Brennan, Christian A. Merlo(Instituto Maimónides de Investigación Biomédica de Córdoba)
American Journal of Transplantation
January 1, 2021
Cited by 0
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2015|4k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k